LabCompass

Shadia I. Jalal

Medicine · Indiana University

Publications

247

Citations

9,765

Est. group size

Recurring co-author estimate

Active years

20

Publishing since 2007

Research summary
AI-generated

Shadia I. Jalal conducts clinical cancer research focused primarily on lung cancer, including non-small cell and small cell lung cancer. The work centers on immunotherapy (treatments that harness the immune system against tumors), clinical trials of new drug combinations, and biomarkers that predict treatment response and side effects. Additional projects address esophageal and gastric cancers, cancer genetic testing, and novel approaches such as fasting-based diets to enhance therapy.

Lung cancer treatment and clinical trialsCancer immunotherapy and immune checkpoint inhibitorsPredictive biomarkers and treatment responseEsophageal and gastric cancer managementNovel therapeutic strategies (e.g., fasting-mimicking diets, drug combinations)

Publication activity has been steady over the decade with year-to-year fluctuation, showing a peak in 2023 and continued output through recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 15.6/year recently
2017: 20 publications172018: 24 publications182019: 21 publications192020: 21 publications202021: 18 publications212022: 13 publications222023: 36 publications36232024: 8 publications242025: 16 publications252026: 5 publications26
Recent publications
Publishes in
  • Journal of Clinical Oncology×47
  • Journal of Thoracic Oncology×13
  • Cancer Research×5
  • bioRxiv (Cold Spring Harbor Laboratory)×5
  • Journal of Pain and Symptom Management×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile